Risk stratification for endometrial cancer: independent and joint effects of polygenic risk score and body mass index in 129,829 UK Biobank participants

子宫内膜癌风险分层:多基因风险评分和体重指数在129,829名英国生物银行参与者中的独立和联合效应

阅读:2

Abstract

BACKGROUND: Although obesity is a well-established risk factor for endometrial cancer, its relationship with genetic susceptibility in determining cancer risk remains unexplored. Current endometrial cancer risk prediction relies primarily on epidemiological factors, with limited consideration of genetic risk. We hypothesized that integrating polygenic risk score (PRS) information with established epidemiological factors could improve risk stratification and reveal whether genetic and lifestyle factors operate independently or jointly. METHODS: We generated a polygenic risk score for endometrial cancer in 129,829 unrelated female participants of European genetic ancestry (including 956 incident cases with endometrial cancer) in the UK Biobank cohort. We evaluated the prediction model performance using area under the receiver operating characteristic curves (AUCs) and assessed individual and joint associations of body mass index (BMI) and PRS with endometrial cancer using Cox proportional hazards models. RESULTS: The integrated model incorporating PRS and epidemiological risk factors achieved statistically significant improvement in predicting endometrial cancer compared with epidemiologic factors alone (AUC = 0.739 versus 0.728; P = 3.98 × 10(-5)). Participants in the top 1% PRS distribution had a 3.06-fold increased risk (95% CI 1.97-4.76), with a number needed to screen of 58 individuals. BMI and PRS demonstrated independent effects on endometrial cancer risk, with participants with a BMI ≥ 30 kg/m(2) in the top PRS tertile showing the highest endometrial cancer risk (HR = 4.94; 95% CI 3.65-6.68). Even participants with a BMI < 25 kg/m(2) in the top PRS tertile had a significantly increased risk (HR = 2.01; 95% CI 1.45-2.78). CONCLUSIONS: Integrating PRS with epidemiological risk factors provides potential for enhanced endometrial cancer risk stratification. PRS effects persist independently of BMI, suggesting genetic risk assessment could complement current screening approaches focused on Lynch Syndrome and identify additional high-risk individuals for targeted prevention strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。